Christian Bjørn Poulsen

Author

Also Known As

Bjørn Poulsen, Christian, C. Bjørn Poulsen, C. Poulsen, C.B Poulsen, C.B. Poulsen, Christian B Poulsen, Christian B. Poulsen, Christian Bjorn Poulsen, Christian Bjørn Poulsen, Christian Bjørn Poulsen

130

Publications

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Odense University Hospital Copenhagen University Hospital Zealand University Hospital Aalborg University Hospital

About

Christian Bjørn Poulsen is an author at Rigshospitalet specializing in medicine, immunology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	434
2	Social Sciences	4	4	161
3	Health Sciences	2	2	89
4	Public Health	1	1	62
5	Cell Biology	1	1	58

Christian Bjørn Poulsen

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Journal of Hematology & Oncology	2021	312
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater, New England Journal of Medicine	2023	268
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas Lena Marquard, Christian Bjørn Poulsen, Lise Mette Rahbek Gjerdrum, Histopathology	2009	130
Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis Milena Penkowa, Carmen Espejo, Eva Martínez‐Cáceres, Journal of Neuroimmunology InflammationAltered Inflammatory ResponseAutoimmune DiseaseMedicineImmunology	2001	74
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines Steen Møller Hansen, Peter Enemark Lund, P Soegaard, British Journal of Haematology Heart FailurePathologyCumulative 5-Year RiskPharmacotherapyCardiovascular Toxicity	2018	62
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht, The Lancet Oncology	2024	59
Profiling of diffuse large B‐cell lymphoma by immunohistochemistry: identification of prognostic subgroups Lene Dissing Sjø, Christian Bjørn Poulsen, Mads Hansen, European Journal Of Haematology	2007	58
Brain response to traumatic brain injury in wild‐type and interleukin‐6 knockout mice: a microarray analysis Christian Bjørn Poulsen, Milena Penkowa, Rehannah Borup, Journal of Neurochemistry Traumatic Brain InjuryImmune RegulationImmunologyCell DeathIl-6 Deficiency	2004	58
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial Arnon P. Kater, Mark‐David Levin, Julie Dubois, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyClinical Trials	2022	55
Microarray‐based classification of diffuse large B‐cell lymphoma Christian Bjørn Poulsen, Rehannah Borup, Finn Cilius Nielsen, European Journal Of Haematology Primary Nodal DlbclImmunologyPathologyTumor BiologyHematological Malignancy	2005	48

Page 1